266 related articles for article (PubMed ID: 23912862)
1. Monitoring survivin expression in cancer: implications for prognosis and therapy.
Santa Cruz Guindalini R; Mathias Machado MC; Garicochea B
Mol Diagn Ther; 2013 Dec; 17(6):331-42. PubMed ID: 23912862
[TBL] [Abstract][Full Text] [Related]
2. Survivin: A molecular biomarker in cancer.
Jaiswal PK; Goel A; Mittal RD
Indian J Med Res; 2015 Apr; 141(4):389-97. PubMed ID: 26112839
[TBL] [Abstract][Full Text] [Related]
3. Survivin as a Potential Target for Cancer Therapy.
Soleimanpour E; Babaei E
Asian Pac J Cancer Prev; 2015; 16(15):6187-91. PubMed ID: 26434815
[TBL] [Abstract][Full Text] [Related]
4. Survivin: an inhibitor of apoptosis in pediatric cancer.
Fangusaro JR; Caldas H; Jiang Y; Altura RA
Pediatr Blood Cancer; 2006 Jul; 47(1):4-13. PubMed ID: 16534789
[TBL] [Abstract][Full Text] [Related]
5. Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules.
Taniguchi H; Horinaka M; Yoshida T; Yano K; Goda AE; Yasuda S; Wakada M; Sakai T
Mol Cancer Ther; 2012 Oct; 11(10):2294-300. PubMed ID: 22784708
[TBL] [Abstract][Full Text] [Related]
6. Survivin--prognostic tumor biomarker in human neoplasms--review.
Waligórska-Stachura J; Jankowska A; Waśko R; Liebert W; Biczysko M; Czarnywojtek A; Baszko-Błaszyk D; Shimek V; Ruchała M
Ginekol Pol; 2012 Jul; 83(7):537-40. PubMed ID: 22880480
[TBL] [Abstract][Full Text] [Related]
7. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
8. Antisense inhibition of survivin expression as a cancer therapeutic.
Carrasco RA; Stamm NB; Marcusson E; Sandusky G; Iversen P; Patel BK
Mol Cancer Ther; 2011 Feb; 10(2):221-32. PubMed ID: 21216939
[TBL] [Abstract][Full Text] [Related]
9. Survivin as a prognostic/predictive marker and molecular target in cancer therapy.
Rödel F; Sprenger T; Kaina B; Liersch T; Rödel C; Fulda S; Hehlgans S
Curr Med Chem; 2012; 19(22):3679-88. PubMed ID: 22680927
[TBL] [Abstract][Full Text] [Related]
10. Survivin as a preferential target for cancer therapy.
Mobahat M; Narendran A; Riabowol K
Int J Mol Sci; 2014 Feb; 15(2):2494-516. PubMed ID: 24531137
[TBL] [Abstract][Full Text] [Related]
11. Is survivin the potential Achilles' heel of cancer?
Lladser A; Sanhueza C; Kiessling R; Quest AF
Adv Cancer Res; 2011; 111():1-37. PubMed ID: 21704829
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathologic relevance of Survivin splice variant expression in cancer.
Necochea-Campion Rd; Chen CS; Mirshahidi S; Howard FD; Wall NR
Cancer Lett; 2013 Oct; 339(2):167-74. PubMed ID: 23791888
[TBL] [Abstract][Full Text] [Related]
13. Survivin in survival of hepatocellular carcinoma.
Su C
Cancer Lett; 2016 Sep; 379(2):184-90. PubMed ID: 26118774
[TBL] [Abstract][Full Text] [Related]
14. Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma.
Chen Z; Liu N; Zhu G; Dralle H; Hoang-Vu C
Int J Mol Med; 2012 Sep; 30(3):465-72. PubMed ID: 22751750
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers.
Singh N; Krishnakumar S; Kanwar RK; Cheung CH; Kanwar JR
Drug Discov Today; 2015 May; 20(5):578-87. PubMed ID: 25433305
[TBL] [Abstract][Full Text] [Related]
16. Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target.
Fang XL; Cao XP; Xiao J; Hu Y; Chen M; Raza HK; Wang HY; He X; Gu JF; Zhang KJ
J Drug Target; 2024 Dec; 32(3):223-240. PubMed ID: 38252514
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
18. Targeting survivin in cancer: novel drug development approaches.
Groner B; Weiss A
BioDrugs; 2014 Feb; 28(1):27-39. PubMed ID: 23955284
[TBL] [Abstract][Full Text] [Related]
19. Effect of survivin on tumor growth of colorectal cancer in vivo.
Cai Y; Ma W; Huang X; Cao L; Li H; Jiang Y; Lu N; Yin Y
Int J Clin Exp Pathol; 2015; 8(10):13267-72. PubMed ID: 26722528
[TBL] [Abstract][Full Text] [Related]
20. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
